EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Garcinol as an Epigenetic Modulator: Mechanisms of Anti-Cancer Activity and Therapeutic Potential

Geethika Pochana, Tejaswini Sai Karanam, Shacoya Mack, Balasubramanyam Karanam iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262210917 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Geethika Pochana und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology and Cancer Research, Tuskegee University, 1200 W Montgomery Rd, Tuskegee, AL 36088, USA. Hauptthemen laut MEDLINE: Terpenes, Epigenesis, Genetic, Neoplasms, Antineoplastic Agents. Die Arbeit nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMHD NIH HHS, NHGRI NIH HHS, National Institute on Minority Health and Health Disparities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The limitations of conventional cancer therapies, including toxicity and resistance, underscore the need for safer and more versatile alternatives that can either complement or substitute existing regimens. Garcinol, a polyisoprenylated benzophenone derived primarily from the rind and leaves of Garcinia indica and Garcinia cambogia, has drawn significant interest in recent decades. Although traditionally used to relieve inflammatory disorders, its biomedical relevance expanded considerably after reports in the late 20th century demonstrated antimicrobial and subsequently anti-cancer properties. A growing body of cell-based research, supported by a smaller set of animal experiments, now suggests that garcinol acts as a potent epigenetic modulator. Its activities include inhibition of histone acetyltransferases (HATs), a groundbreaking research followed by regulation of oncogenic microRNAs, and modulation of signaling pathways critical to tumor progression. This review integrates current findings on garcinol’s dual role as a HAT inhibitor and regulator of oncogenic networks with updates on in vitro and in vivo studies with a more focused approach on in vivo animal models, highlighting its potential as an emerging therapeutic against malignancies and inflammatory diseases. Nonetheless, translation into clinical settings remains premature, as robust in vivo evidence is sparse and human trials are lacking. Moving forward, systematic investigations are required to clarify safety profiles, establish effective dosing strategies, and evaluate its efficacy across different cancer types.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TerpenesEpigenesis, GeneticNeoplasmsAntineoplastic AgentsHumansAnimalsHistone AcetyltransferasesMicroRNAsGene Expression Regulation, NeoplasticSignal Transduction

Stichwörter der Autor:innen

Garcinia cambogiaGarcinia indicaapoptosiscambogincancergarcinolhistone acetyltransferasespolyisoprenylated benzophenone

Substanzen

garcinolTerpenesHistone AcetyltransferasesAntineoplastic AgentsMicroRNAs

Autor:innen und Institutionen

  • Department of Biology and Cancer Research, Tuskegee University, 1200 W Montgomery Rd, Tuskegee, AL 36088, USA.

ORCID-Profile: Balasubramanyam Karanam

Förderung

  • NIMHD NIH HHS
  • NHGRI NIH HHS
  • National Institute on Minority Health and Health Disparities
  • National Human Genome Research Institute

Zitieren

APA

Pochana, G., Karanam, T. S., Mack, S., & Karanam, B. (2025). Garcinol as an Epigenetic Modulator: Mechanisms of Anti-Cancer Activity and Therapeutic Potential. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262210917

Vancouver

Pochana G, Karanam TS, Mack S, Karanam B. Garcinol as an Epigenetic Modulator: Mechanisms of Anti-Cancer Activity and Therapeutic Potential. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262210917

BibTeX
@article{Pochana2025,
  author = {Pochana, Geethika and Karanam, Tejaswini Sai and Mack, Shacoya and Karanam, Balasubramanyam},
  title = {Garcinol as an Epigenetic Modulator: Mechanisms of Anti-Cancer Activity and Therapeutic Potential},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262210917}
}
Kostenlos starten →